NextVision Stock Plummets 50% From Peak, Presenting Opportunity for Patient Investors

The Israeli business publication Globes has launched a new bi-weekly column analyzing Israeli stocks, focusing on mid-cap companies. The inaugural piece examines NextVision, a manufacturer of stabilized cameras for drones, which has experienced a dramatic rise and fall in its stock value. The company, which went public in June 2021, initially offered investors a return of over 3000%, reaching a peak market value of approximately 36 billion shekels in early March. However, a shift in market sentiment towards the defense sector, coupled with significant stock sales by founders and stakeholders totaling around 1.6 billion shekels, and a large technical sale by Fidelity fund in October worth approximately 1.3 billion shekels, caused the stock to drop by over 50% to its current valuation of about 17 billion shekels. Despite the sharp decline, Israeli institutional investors have been acquiring shares worth hundreds of millions of shekels.

NextVision's core business involves developing and producing stabilized camera solutions for both aerial and ground vehicles, serving as crucial "eyes" for intelligence and combat drones. The company's competitive edge lies in its superior weight-to-size-to-performance ratio, operational experience, and financial stability, allowing it to maintain substantial inventory and fulfill large orders quickly. Its strategic growth is fueled by a global shift in the defense market towards massive rearmament and stockpile building, supported by increased defense budgets in Europe, the US, and India.

To meet rising demand, NextVision is tripling its production capacity this year, aiming for over 5,000 units per month by year-end. The company is also planning to establish a production line in Europe to shorten delivery times and navigate regulatory hurdles. Furthermore, NextVision is expanding into new niches like drone interception systems and integrating more advanced, costly cooled systems, which are expected to increase the average selling price.

Financially, NextVision reported a 138% surge in second-quarter revenues to approximately $88.2 million, with a healthy gross profit margin of 65.2% and an operating profit margin of 58.8%. The company boasts a debt-free balance sheet, strong cash flow, and a substantial cash reserve of about $600 million. Management has raised its annual revenue forecast to $355 million, an 111% increase from 2025, with a backlog of orders standing at approximately $265 million as of August.

Despite the positive fundamentals, potential risks include the entry of cheaper competitors, the short-term nature of its order backlog (about 75% for the next 12 months), and a high concentration of revenue from its top three clients, who account for nearly 66% of second-quarter income. International investment firms Needham and UBS have initiated coverage with "buy" recommendations and target prices of 275 shekels and 434 shekels, respectively. The stock is also expected to benefit from passive demand of about 65 million shekels following an upcoming index rebalancing. The article concludes that while the stock's current valuation is attractive for medium to long-term investment, significant patience is required due to the stock's negative momentum.